Growth and Site to Site Comparison of a HEK Fed-Batch Process in Stratyx™ 250

Reproducibility across labs is critical for adopting new bioprocessing technologies. In this white paper, we present results from a multi-site evaluation of the Stratyx™ 250 bioreactor platform, testing its consistency across three independent locations—including two non-Culture Biosciences labs. Using a fed-batch HEK cell process known for its sensitivity to variation, we assessed performance across different operators, equipment, and SOPs. Key metrics like viable cell density, viability, and lactate production showed consistent results across all sites. Download the white paper to see how the Stratyx 250 delivers reliable, reproducible performance wherever it's used.